1. Home
  2. Live Updates
  3. Patients with

Live Breaking News & Updates on Patients with

Stay informed with the latest breaking news from Patients with on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Patients with and stay connected to the pulse of your community

Opioid Use Disorder Research Roundup: April 19, 2024

What is new in research on opioid use disorder?

Research-roundup , International-classification-of-diseases , Problematic-internet-use , Patients-with , International-classification , Des-marais ,

ImPrint Identifies Treatment for Patients With Breast Cancer

Data from the ongoing phase 2 trial show that clinicians can use ImPrint, an immune-related biomarker, to identify breast cancer patients who are likely to respond to neoadjuvant immunotherapy.

United-states , San-francisco , California , American , Denisem-wolf , American-association-for-cancer-research , Msc-of-the-university-california , University-of-alabama-at-birmingham , Using-imprint , American-association , Cancer-research

When Does the PD-1 Inhibitor Come Before the Hedgehog Inhibitor for Neoadjuvant BCC/CSCC?

Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers.

Boston , Massachusetts , United-states , Washington , France , Stanford , California , Florida , Texas , Houston , University-of-california-san-francisco , Vishala-patel

Individualizing Therapy Goals for Patients With Myelofibrosis

Andrew Kuykendall, MD, emphasizes the importance of individualizing therapy for patients with myelofibrosis, focusing on improving quality of life and addressing specific issues like anemia and spleen volume, with the understanding that these treatments are palliative and goals should be revisited regularly.

Andrew-kuykendall , Treating-myelofibrosis , Therapy-goals , Patients-with ,

LuGENE blood test for lupus flares, drug targets enters open-label study

LuGENE blood test for lupus flares, drug targets enters open-label study
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states , Peter-lipsky , Shenaz-bagha , Amrie-grammer , Lugene-multiparameter-transcriptomics , Standard-laboratory-features-of-patients-with , Yale-school-of-medicine , Cleveland-clinic , Mayo-clinic , Yale-school , Relationship-between-data-obtained-with , Transcriptomics-blood-test

Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024

Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Italy , American , Dennis-riedl , Eric-hughes , Yael-ashman , Eden-klein , Kelley-dougherty , Pharmacokinetic-pop , Sanjeev-sharma , National-pregnancy-registry-for-atypical-antipsychotics , Population-pharmacokinetic-modeling-following-administration-of-olanzapine

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Italy , United-states , American , Eric-hughes , Sanjeev-sharma , Eden-klein , Yael-ashman , Pharmacokinetic-pop , Kelley-dougherty , Teva-neuroscience-inc , National-pregnancy-registry-for-atypical-antipsychotics , International-survey-study-to-assess-the-perceptions

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024

PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable formulation of risperidone microspheres



Additional UZEDY...

United-states , Italy , American , Pharmacokinetic-pop , Eric-hughes , Drug-administration , Teva-pharmaceuticals , Population-pharmacokinetic-modeling-following-administration-of-olanzapine , Mental-health-services-administration , Teva-neuroscience-inc , International-survey-study-to-assess-the-perceptions , National-pregnancy-registry-for-atypical-antipsychotics

New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease

New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Spain , London , City-of , United-kingdom , South-dakota , China , Chinese , Spanish , American

ACC 2024: U-Mich Experts for Comment on Late-Breaking Trials, Featured Research

Hi there,
Tomorrow begins the ACC 73rd Annual Scientific Sessions in Atlanta. Experts from the University of Michigan Health Frankel Cardiovascular Center have

United-states , American , Brahmajee-nallamothu , Eric-cantey , Marvinm-kirsh , Toddm-koelling , Stanleyj-chetcuti , Kent-brummel , Scott-hummel , Gorav-ailawadi , John-bisognano , Ericj-topol